Dr. Sara Eggers directs the Decision Support and Analysis Staff within FDA’s Center for Drug Evaluation and Research. This staff leverages decision science principles and tools to help structure, inform, and effectively communicate the Center’s drug regulatory decision-making. Through this work, Dr. Eggers has contributed decision science expertise to initiatives regarding drug benefit-risk assessment, patient-focused drug development, product quality assessments, drug safety labeling, risk evaluation and mitigation strategies, and others. In addition, she co-leads an FDA effort utilizing systems modeling to inform policies to address the opioids crisis. Before joining FDA in 2011, she conducted research and consulting in the area of decision science, stakeholder engagement, risk management, and risk communication. Dr. Eggers has a Ph.D. in Engineering and Public Policy from Carnegie Mellon University.